News

Versantis receives U.S. FDA Orphan Drug Designation for VS-01

Versantis AG, a clinical-stage company developing novel therapies for rare liver diseases and rare pediatric diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to its lead product candidate VS-01 for the treatment of hyperammonemia (HA) in inborn errors of metabolism (IEM).

weiterlesen

Additional funds for Positrigo

With a further EUR 1.5 million from the European Innovation Council EIC Fund, Technopark Zurich based  Medtech Positrigo is one of the first companies to receive equity funding under the EIC Accelerator programme. The funds will contribute to the second tranche of Positrigo’s series A and support the start-up’s breakthrough brain PET scanner technology.

weiterlesen

The Swiss FoodTech Ecosystem at a glance

With over 280 influential Swiss FoodTech startups (including Technopark Zurich based Planted) and ecosystem partners, IT infrastructure, R&D laboratories, incubators, Switzerland is poised to grow and become a trailblazer in the FoodTech sector. A report by Accenture and the Swiss Food & Nutrition Valley sheds light on the landscape.

weiterlesen

The Swiss FinTech Awards 2021 go to FQX and Yokoy

The Swiss Fintech Awards have established themselves as an important annual award for start-ups from the highly dynamic vertical. This year, two start-ups came out on top, which significantly simplify tedious and complex processes through digitisation. Zum Beitrag auf Startupticker

weiterlesen